Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway
.@stacyblain@concarlo760 discusses drug resistance in cacner, the company’s efforts to target a driver of cell proliferation that is reactivated once a cancer grows resistant to certain targeted therapies, and her own journey from academia to biopharma.
https://t.co/GfaCitia4K
.@stacyblain@concarlo760 discusses drug resistance in cacner, the company’s efforts to target a driver of cell proliferation that is reactivated once a cancer grows resistant to certain targeted therapies, and her own journey from academia to biopharma.
https://t.co/7ErvTH9fLl
Stacy Blain CEO of Concarlo Therapeutics (@concarlo760) shares how she started up a company focused on oncology & navigated an industry dominated by men #femaleleadership
https://t.co/EGLDqVhKNu
Don't miss our Chief Development Officer Krishna Allamneni today on the UCSB Medical Reallocation Initiative Health Panel at 7pm! Scan the QR code at the bottom right corner of the flyer to tune in. #healthcare#health
Did you catch our CEO Stacy Blain on the Beyond Biotech Podcast? Tune in now to learn more about how Concarlo. https://t.co/t4qx75zaS6 #biotech#tech#health#cancer#innovation
Are you attending Biocom California? If you're interested in learning more about Concarlo Therapeutics and our mission to create transformative solutions for drug-resistant cancer, please reach out. We would love to chat! #biocom#breastcancer#cancer#health